[Validity of the Spanish version of the Addenbrooke's Cognitive Examination for the diagnosis of dementia and to differentiate Alzheimer's disease and frontotemporal dementia]. / El Addenbrooke's Cognitive Examination en español para el diagnóstico de demencia y para la diferenciación entre enfermedad de Alzheimer y demencia frontotemporal.

INTRODUCTION: The Addenbrooke's Cognitive Examination (ACE) is a brief bedside test battery to detect mild dementia and differentiate frontotemporal dementia (FTD) from Alzheimer's disease (AD). AIM: To validate the ACE in Spanish. PATIENTS AND METHODS: The study evaluated the Spanish version of ACE on 128 subjects consisting in two groups a patient group (n = 76) and a control subjects group (n = 52). The patient group was divided in AD (n = 54) based on the NINCDS-ADRDA criteria and FTD (n = 22) based on the Lund y Manchester criteria. All patients underwent clinical, neuropsychological, radiologic (MRI, CT, and SPECT), and laboratory evaluations. Group's differences were evaluated using ANOVA. The internal consistency of the Spanish version of the ACE was measured using the Cronbach's alpha coefficient. The discriminative capability of the Spanish version of the ACE was examined by the receiver operating characteristic (ROC) analysis. RESULTS: The cut-off score of 86 showed a sensitivity of 92% (CI 95% = 83.6-97.0) and a specificity of 96.2% (CI 95% = 86.8-99.4). The ROC curve showed higher sensitivity and specificity of the ACE than the Mini-Mental State Examination in discriminating the dementia and control group. The VLOM ratio (verbal fluency + language)/(orientation + memory) of < 1.82 discriminated for FTD and > 4.87 discriminated for AD. CONCLUSION: The Spanish version of ACE is a brief and reliable instrument for early detection of dementia in highly educated people and offers a simple objective index to differentiate AD and FTD. More studies in less educated people are warranted.

El Addenbrooke’s Cognitive Examination en español para el diagnóstico de demencia y para la diferenciación entre enfermedad de Alzheimer y demencia frontotemporal / Validity of the spanish version of the addenbrooke’s cognitive examination for the diagnosis of dementia and to differentiate alzheimer’s disease and frontotemporal dementia

Introducción. Existe una creciente necesidad de contar con un instrumento breve y fiable que permita detectar demencia en los estadios iniciales. Objetivo. Validar la traducción al español del Addenbrooke’s Cognitive Examination (ACE), una batería breve recientemente desarrollada y validada en inglés para detectar demencia y diferenciar la demencia tipo Alzheimer (DTA) de la demencia frontotemporal (DFT). Pacientes y métodos. Se estudiaron los siguientes grupos: controles (n = 52), DFT según criterios del consenso de Lund y Manchester (n = 22) y pacientes con probable DTA (n = 54) según criterios del NINCDS-ADRDA. A todos los pacientes se les realizó una batería neuropsicológica estándar, inventarios neuropsiquiátricos y neuroimágenes. La diferencia entre grupos se evaluó con ANOVA y la consistencia interna del cuestionario mediante el coeficiente α de Cronbach. La elección del punto de corte se realizó mediante la curva ROC (del inglés receiver operating characteristics). Resultados. El test mostró una aceptable coherencia interna. El cut-off de 86 arrojó una sensibilidad del 92% (IC 95%: 83,6-97,0) y especificidad del 96,2% (IC 95%: 86,8-99,4). La curva ROC demostró mayor sensibilidad y especificidad del ACE sobre el Mini-Mental State Examination para discriminar entre grupo control y demencia. El coeficiente VLOM (fluidez verbal + lenguaje) / (orientación + recuerdo diferido) permite orientar el diagnóstico hacia DFT si el valor es menor de 1,82 y hacia DTA si es mayor de 4,87. Conclusión. La versión en español del ACE posee buena especificidad y sensibilidad para la detección de demencia en población de alto nivel educativo y permite orientar el diagnóstico diferencial entre DFT y DTA. Se necesitan nuevos estudios en población de menor escolaridad

Introduction. The Addenbrooke’s Cognitive Examination (ACE) is a brief bedside test battery to detect mild dementia and differentiate frontotemporal dementia (FTD) from Alzheimer’s disease (AD). Aim. To validate the ACE in Spanish. Patients and methods. The study evaluated the Spanish version of ACE on 128 subjects consisting in two groups a patient group (n = 76) and a control subjects group (n = 52). The patient group was divided in AD (n = 54) based on the NINCDS-ADRDA criteria and FTD (n = 22) based on the Lund y Manchester criteria. All patients underwent clinical, neuropsychological, radiologic (MRI, CT, and SPECT), and laboratory evaluations. Group’s differences were evaluated using ANOVA. The internal consistency of the Spanish version of the ACE was measured using the Cronbach’s alpha coefficient. The discriminative capability of the Spanish version of the ACE was examined by the receiver operating characteristic (ROC) analysis. Results. The cut-off score of 86 showed a sensitivity of 92% (CI 95% = 83.6-97.0) and a specificity of 96.2% (CI 95% = 86.8-99.4). The ROC curve showed higher sensitivity and specificity of the ACE than the Mini-Mental State Examination in discriminating the dementia and control group. The VLOM ratio (verbal fluency + language) / (orientation + memory) of 4.87 discriminated for AD. Conclusion. The Spanish version of ACE is a brief and reliable instrument for early detection of dementia in highly educated people and offers a simple objective index to differentiate AD and FTD. More studies in less educated people are warranted